Last reviewed · How we verify
NCT06642922: BMI
Gross Motor Abnormalities in Relation to Balance and Weight Indicators in Diplegia
trial in Spastic Diplegia Cerebral Palsy in 104 participants. Completed in 12 July 2023.
15 June 2023
Quick facts
| Lead sponsor | Lamis Neyazy Elrakhawy |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 104 |
| Start date | 20 October 2022 |
| Primary completion | 15 June 2023 |
| Estimated completion | 12 July 2023 |
| Sites | 1 location across Egypt |
Conditions studied
- Spastic Diplegia Cerebral Palsy — all drugs for Spastic Diplegia Cerebral Palsy →
Sponsor
Lamis Neyazy Elrakhawy
Who can join
Adults 5 to 10, any sex, with Spastic Diplegia Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to investigate the correlation between BMI and balance and gross motor capacities in children with spastic diplegia. The main question it aims to answer is: Is there a correlation between BMI, balance disturbances and gross motor capacity in children with spastic diplegic cerebral palsy? Researchers compared between results of biodex balance system , GMFM and BMI measures participants stood on biodex balance platform for balance measurement and performed Gross Motor Function Measurement items for gross motor capacities assessment
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06642922
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Spastic Diplegia Cerebral Palsy
Currently open trials in the same condition.
- NCT06686719 — Post Facilitation Stretch, Post Isometric Relaxation and Myofascial Release in Spastic Cerebral Palsy. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06642922 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lamis Neyazy Elrakhawy
- Last refreshed: 17 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06642922.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing